MedPath

Chronic Total Occlusion Registry

Terminated
Conditions
Coronary Stenosis
Coronary Occlusion
Coronary Artery Stenosis
Interventions
Procedure: Percutaneous coronary intervention
Procedure: Coronary Artery Bypass Grafting
Drug: Medical treatment
Registration Number
NCT04041921
Lead Sponsor
Seung-Jung Park
Brief Summary

This study evaluated the long-term outcome of patients with chronic total occlusion treated with percutaneous coronary intervention, medical treatment or coronary artery bypass grafting.

Detailed Description

This study is connected with Decision-CTO trial(NCT01078051). Randomized subjects and registry group subjects from Decision-CTO trial continue 10 years follow-up on this study.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4006
Inclusion Criteria
  • Patients with angina or silent ischemia and documented ischemia
  • Patients with De novo chronic coronary occlusion ≥ 3months and reference diameter ≥ 2.5 mm on coronary angiography
  • Age > 18 years
Exclusion Criteria
  • Refuse to participate in this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Chronic coronary occlusion patientsPercutaneous coronary intervention≥3 months chronic total occlusion on coronary angiography
Chronic coronary occlusion patientsCoronary Artery Bypass Grafting≥3 months chronic total occlusion on coronary angiography
Chronic coronary occlusion patientsMedical treatment≥3 months chronic total occlusion on coronary angiography
Primary Outcome Measures
NameTimeMethod
Composite event of all cause death, myocardial infarction, stroke or all kinds of repeat revascularization10 years
Secondary Outcome Measures
NameTimeMethod
Event rate of all cause death10 years
Event rate of rehospitalization due to acute coronary syndrome10 years
Event rate of acute myocardial infarction10 years
Event rate of stroke10 years
Event rate of Procedural success5 days

Procedural success is defined as \< 30% final stenosis and the absence of in-hospital event including death, Q-wave myocardial infarction or urgent repeat revascularization.

Event rate of repeat revascularization10 years
The rate change of left ventricular ejection fraction10 years
Composite event of death, myocardial, stroke or repeat revascularization10 years

Trial Locations

Locations (19)

The Catholic University of Korea, Daejeon ST. Mary's Hospital

🇰🇷

Daejeon, Korea, Republic of

Soon Chun Hyang University Hospital Cheonan

🇰🇷

Cheonan, Korea, Republic of

Asan Medical Hospital

🇰🇷

Seoul, Korea, Republic of

SAM hospital

🇰🇷

Anyang, Korea, Republic of

Chonnam National University Hospital

🇰🇷

Gwangju, Korea, Republic of

Soon Chun Hyang University Hospital Bucheon

🇰🇷

Bucheon, Korea, Republic of

Chungbuk National University Hospital

🇰🇷

Cheongju, Korea, Republic of

Gangwon National Univ. Hospital

🇰🇷

Chuncheon, Korea, Republic of

Dong-A Medical Center

🇰🇷

Pusan, Korea, Republic of

Gangneung Asan Hospital

🇰🇷

Gangneung, Korea, Republic of

Bundang CHA Hospital

🇰🇷

Seongnam, Korea, Republic of

ChonBuk National University Hospital

🇰🇷

Jeonju, Korea, Republic of

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

The Catholic University of Korea Seoul St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Wonju Severance Christian Hospital

🇰🇷

Wonju, Korea, Republic of

Ulsan University Hospital

🇰🇷

Ulsan, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Pusan National University Yangsan Hospital

🇰🇷

Pusan, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath